THU0182 Significant reduction in serious upper gastrointestinal (ugi) events with celecoxib, a cox-2 specific inhibitor, compared with conventional nsaids. the success i trial
THU0182 Significant reduction in serious upper gastrointestinal (ugi) events with celecoxib, a cox-2 specific inhibitor, compared with conventional nsaids. the success i trial